| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6132005
[patent_doc_number] => 20020077460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-20
[patent_title] => 'Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells'
[patent_app_type] => new
[patent_app_number] => 09/880939
[patent_app_country] => US
[patent_app_date] => 2001-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 21078
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20020077460.pdf
[firstpage_image] =>[orig_patent_app_number] => 09880939
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/880939 | Methods of administering antibodies that specifically bind ACT-4-L-h-1 ligand | Jun 14, 2001 | Issued |
Array
(
[id] => 1413666
[patent_doc_number] => 06528623
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-03-04
[patent_title] => 'Antibodies that specifically bind ACT-4-L-h-1 ligand'
[patent_app_type] => B2
[patent_app_number] => 09/804200
[patent_app_country] => US
[patent_app_date] => 2001-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 21562
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/528/06528623.pdf
[firstpage_image] =>[orig_patent_app_number] => 09804200
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/804200 | Antibodies that specifically bind ACT-4-L-h-1 ligand | Mar 12, 2001 | Issued |
Array
(
[id] => 1400091
[patent_doc_number] => 06534288
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-18
[patent_title] => 'C peptide for improved preparation of insulin and insulin analogs'
[patent_app_type] => B1
[patent_app_number] => 09/676787
[patent_app_country] => US
[patent_app_date] => 2000-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4463
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/534/06534288.pdf
[firstpage_image] =>[orig_patent_app_number] => 09676787
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/676787 | C peptide for improved preparation of insulin and insulin analogs | Oct 1, 2000 | Issued |
Array
(
[id] => 1342245
[patent_doc_number] => 06586389
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-01
[patent_title] => 'Cubilin protein, DNA sequences encoding cubilin and uses thereof'
[patent_app_type] => B1
[patent_app_number] => 09/341461
[patent_app_country] => US
[patent_app_date] => 2000-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 31
[patent_no_of_words] => 25519
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/586/06586389.pdf
[firstpage_image] =>[orig_patent_app_number] => 09341461
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/341461 | Cubilin protein, DNA sequences encoding cubilin and uses thereof | Jul 19, 2000 | Issued |
| 09/618150 | 33 human secreted proteins | Jul 16, 2000 | Abandoned |
| 09/603825 | SOLUBLE CTLA4 MUTANT MOLECULES AND USES THEREOF | Jun 25, 2000 | Abandoned |
| 09/574750 | Novel FGF homologs | May 17, 2000 | Abandoned |
Array
(
[id] => 1410091
[patent_doc_number] => 06521233
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-18
[patent_title] => 'Adipocyte complement related protein homolog zacrp3'
[patent_app_type] => B1
[patent_app_number] => 09/552225
[patent_app_country] => US
[patent_app_date] => 2000-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 31107
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/521/06521233.pdf
[firstpage_image] =>[orig_patent_app_number] => 09552225
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/552225 | Adipocyte complement related protein homolog zacrp3 | Apr 18, 2000 | Issued |
Array
(
[id] => 1391834
[patent_doc_number] => 06541232
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-01
[patent_title] => 'Polypeptides having kinase activity'
[patent_app_type] => B1
[patent_app_number] => 09/544794
[patent_app_country] => US
[patent_app_date] => 2000-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22953
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/541/06541232.pdf
[firstpage_image] =>[orig_patent_app_number] => 09544794
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/544794 | Polypeptides having kinase activity | Apr 6, 2000 | Issued |
Array
(
[id] => 1419661
[patent_doc_number] => 06518404
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-11
[patent_title] => 'Human endothelin-bombesin receptor antibodies'
[patent_app_type] => B1
[patent_app_number] => 09/520210
[patent_app_country] => US
[patent_app_date] => 2000-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 18171
[patent_no_of_claims] => 144
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/518/06518404.pdf
[firstpage_image] =>[orig_patent_app_number] => 09520210
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/520210 | Human endothelin-bombesin receptor antibodies | Mar 6, 2000 | Issued |
| 09/514010 | Secreted proteins and uses thereof | Feb 24, 2000 | Abandoned |
| 09/474071 | SECRETED PROTEINS AND USES THEREOF | Dec 28, 1999 | Abandoned |
Array
(
[id] => 4404656
[patent_doc_number] => 06171822
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-09
[patent_title] => 'Stanniocalcin-2'
[patent_app_type] => 1
[patent_app_number] => 9/416150
[patent_app_country] => US
[patent_app_date] => 1999-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 17516
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/171/06171822.pdf
[firstpage_image] =>[orig_patent_app_number] => 416150
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/416150 | Stanniocalcin-2 | Oct 10, 1999 | Issued |
Array
(
[id] => 1028109
[patent_doc_number] => 06881826
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-04-19
[patent_title] => 'Imidazoline receptive polypeptides'
[patent_app_type] => utility
[patent_app_number] => 09/414643
[patent_app_country] => US
[patent_app_date] => 1999-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 12716
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/881/06881826.pdf
[firstpage_image] =>[orig_patent_app_number] => 09414643
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/414643 | Imidazoline receptive polypeptides | Oct 7, 1999 | Issued |
Array
(
[id] => 1357437
[patent_doc_number] => 06576742
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-06-10
[patent_title] => 'DNA sequence encoding a human imidazoline receptor and method for cloning the same'
[patent_app_type] => B1
[patent_app_number] => 09/389487
[patent_app_country] => US
[patent_app_date] => 1999-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 13987
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/576/06576742.pdf
[firstpage_image] =>[orig_patent_app_number] => 09389487
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/389487 | DNA sequence encoding a human imidazoline receptor and method for cloning the same | Sep 2, 1999 | Issued |
| 09/369693 | NOVEL MOLECULES OF THE TANGO-93-RELATED PROTEIN FAMILY AND USES THEREOF | Aug 5, 1999 | Abandoned |
| 09/362870 | HUMAN XAG-2 POLYNUCLEOTIDES AND POLYPEPTIDES | Jul 28, 1999 | Abandoned |
Array
(
[id] => 1543643
[patent_doc_number] => 06372891
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-16
[patent_title] => 'Human G-protein receptor HPRAJ70'
[patent_app_type] => B1
[patent_app_number] => 09/339115
[patent_app_country] => US
[patent_app_date] => 1999-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12162
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/372/06372891.pdf
[firstpage_image] =>[orig_patent_app_number] => 09339115
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/339115 | Human G-protein receptor HPRAJ70 | Jun 23, 1999 | Issued |
| 09/317850 | EPIDERMAL DIFFERENTIATION FACTOR | May 24, 1999 | Abandoned |
| 09/117884 | CYTOKINE EXPRESSED BY DIA/LIF-DEFICIENT EMBRYONIC STEM CELLS FOR THE INHIBITION OF DIFFERENTIATION | May 2, 1999 | Abandoned |